Logo image of ZIXI

Zix Corp (ZIXI) Stock Fundamental Analysis

NASDAQ:ZIXI - Nasdaq - Common Stock

8.485  -0.01 (-0.06%)

After market: 8.485 0 (0%)

Fundamental Rating

2

ZIXI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. ZIXI may be in some trouble as it scores bad on both profitability and health. ZIXI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ZIXI was profitable.
ZIXI Yearly Net Income VS EBIT VS OCF VS FCFZIXI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 10M -10M 20M 30M

1.2 Ratios

Industry RankSector Rank
ROA -2.38%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZIXI Yearly ROA, ROE, ROICZIXI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 10 -10 20

1.3 Margins

Industry RankSector Rank
OM -0.24%
PM (TTM) -4.38%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZIXI Yearly Profit, Operating, Gross MarginsZIXI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 20 40 60 80

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for ZIXI has been increased compared to 1 year ago.
The debt/assets ratio for ZIXI is higher compared to a year ago.
ZIXI Yearly Shares OutstandingZIXI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 10M 20M 30M 40M 50M
ZIXI Yearly Total Debt VS Total AssetsZIXI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 100M 200M 300M 400M

2.2 Solvency

ZIXI has an Altman-Z score of 0.58. This is a bad value and indicates that ZIXI is not financially healthy and even has some risk of bankruptcy.
ZIXI has a Debt/Equity ratio of 1.37. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Altman-Z 0.58
ROIC/WACCN/A
WACCN/A
ZIXI Yearly LT Debt VS Equity VS FCFZIXI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.76 indicates that ZIXI may have some problems paying its short term obligations.
A Quick Ratio of 0.76 indicates that ZIXI may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.76
ZIXI Yearly Current Assets VS Current LiabilitesZIXI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.35% over the past year.
ZIXI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.42% yearly.
Looking at the last year, ZIXI shows a quite strong growth in Revenue. The Revenue has grown by 16.39% in the last year.
The Revenue has been growing by 31.91% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)4.35%
EPS 3Y29.28%
EPS 5Y22.42%
EPS Q2Q%-11.76%
Revenue 1Y (TTM)16.39%
Revenue growth 3Y49.27%
Revenue growth 5Y31.91%
Sales Q2Q%18.25%

3.2 Future

Based on estimates for the next years, ZIXI will show a small growth in Earnings Per Share. The EPS will grow by 6.20% on average per year.
ZIXI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.54% yearly.
EPS Next Y-0.53%
EPS Next 2Y6.88%
EPS Next 3Y6.07%
EPS Next 5Y6.2%
Revenue Next Year16.62%
Revenue Next 2Y15.11%
Revenue Next 3Y14.35%
Revenue Next 5Y14.54%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ZIXI Yearly Revenue VS EstimatesZIXI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ZIXI Yearly EPS VS EstimatesZIXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.14, ZIXI is valued correctly.
Compared to an average S&P500 Price/Earnings ratio of 29.62, ZIXI is valued rather cheaply.
A Price/Forward Earnings ratio of 12.28 indicates a correct valuation of ZIXI.
ZIXI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.70.
Industry RankSector Rank
PE 14.14
Fwd PE 12.28
ZIXI Price Earnings VS Forward Price EarningsZIXI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.57
ZIXI Per share dataZIXI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.63
EPS Next 2Y6.88%
EPS Next 3Y6.07%

More info and screens

0

5. Dividend

5.1 Amount

ZIXI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Zix Corp

NASDAQ:ZIXI (12/22/2021, 8:55:27 PM)

After market: 8.485 0 (0%)

8.485

-0.01 (-0.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)02-28 2022-02-28/amc
Inst Owners0.03%
Inst Owner Change0%
Ins Owners1.39%
Ins Owner Change0%
Market Cap468.20M
Analysts78
Price Target10.2 (20.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.14
Fwd PE 12.28
P/S 1.91
P/FCF N/A
P/OCF N/A
P/B 3.08
P/tB N/A
EV/EBITDA 17.57
EPS(TTM)0.6
EY7.07%
EPS(NY)0.69
Fwd EY8.14%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.45
BVpS2.76
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.63
Profitability
Industry RankSector Rank
ROA -2.38%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -0.24%
PM (TTM) -4.38%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.76
Altman-Z 0.58
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.35%
EPS 3Y29.28%
EPS 5Y22.42%
EPS Q2Q%-11.76%
EPS Next Y-0.53%
EPS Next 2Y6.88%
EPS Next 3Y6.07%
EPS Next 5Y6.2%
Revenue 1Y (TTM)16.39%
Revenue growth 3Y49.27%
Revenue growth 5Y31.91%
Sales Q2Q%18.25%
Revenue Next Year16.62%
Revenue Next 2Y15.11%
Revenue Next 3Y14.35%
Revenue Next 5Y14.54%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A